Sign in and upgrade to a paid plan to export dividends as CSV.
Sign in and upgrade to a paid plan to export dividends as CSV.

BANDARAM PHARMA PACKTECH LIMITED

Healthcare · Healthcare Services

BSE: 524602
₹19.99
▲ 0.05 (0.25%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
30/100
Weak
Valuation
97/100
Undervalued
Momentum
48/100
Neutral

QVM read Cheap on its own multiples Quality Weak, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹36 Cr
PE (TTM)
Data unavailable.
Price to Book
1.1
PEG (TTM)
Data unavailable (needs 8 quarters of EPS).
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-54.1
Free Cash Flow
₹-5 Cr
as of March 31, 2026
Industry median ₹1 Cr (75 companies)
EPS Growth (YoY)
190.91%
as of June 30, 2026
Industry median 13.27% (57 companies)
Net Profit Growth (TTM)
-1086.67%
as of June 30, 2026
Industry median 7.21% (57 companies)
Operating Revenue Growth (TTM)
28.49%
as of June 30, 2026
Industry median 12.82% (57 companies)
Profit Growth (YoY)
-32.71%
as of June 30, 2026
Industry median 8.53% (57 companies)
Revenue Growth (YoY)
294.32%
as of June 30, 2026
Industry median 18.84% (52 companies)
Current Ratio
1.66
as of March 31, 2026
Industry median 2.06 (74 companies)
Debt to Equity
0.76
as of March 31, 2026
Industry median 0.11 (62 companies)
Interest Coverage
-4159.00
as of June 30, 2026
Industry median 7.94 (57 companies)
Net Margin
-11.96%
as of June 30, 2026
Industry median 9.88% (61 companies)
Operating Margin (EBIT)
-11.96%
as of June 30, 2026
Industry median 17.21% (61 companies)
Operating Margin (TTM)
-9.46%
as of June 30, 2026
Industry median 16.20% (59 companies)
Return on Assets
-2.14%
as of March 31, 2026
Industry median 5.40% (58 companies)
Return on Capital Employed
-4.23%
as of March 31, 2026
Industry median 10.44% (56 companies)
Return on Equity
-3.43%
as of March 31, 2026
Industry median 10.16% (58 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 6 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • No Debt to equity is below 0.5 (0.76)
  • No Return on equity is 15% or more (-3.4%)
  • Yes Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 3 met
  • No FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • Yes Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

1 of 5 met
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
0.3%
Low 19.4500 · High 21.5000
1W return
-3.7%
Low 19.0100 · High 21.5000
1M return
7.5%
Low 18.5000 · High 23.5000
52W return
-56.9%
Low 17.2500 · High 23.5000
Lifetime High ₹76.5900 (May 8, 2023)
Lifetime Low ₹0.5200 (June 3, 2013)

Full price history and technicals →

EMA & SMA

Bullish0
Bearish6
5D
20.3
10D
20.5
20D
20.7
50D
23.1
100D
26.8
200D
32.8

Delivery and volume

Day avg. delivery
86.9%
Week avg. delivery
88.0%
Month avg. delivery
78.2%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

20.31
Pivot
First resistance21.18
Second resistance22.36
Third resistance23.23
First support19.13
Second support18.26
Third support17.08
Day RSI44.1
Day MFI42.0
Day MACD-0.52
Day MACD signal-0.66

Beta

1M-0.24
3M-0.86
1Y-0.86
3Y0.16

Price change analysis

↑ 7.5%
Over 1 Month
LowHigh
18.5023.50
↓ -56.9%
Over 3 Months
LowHigh
17.2523.50
↓ -56.9%
Over 6 Months
LowHigh
17.2523.50
↓ -56.9%
Over 1 Year
LowHigh
17.2523.50
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →

Data unavailable (needs at least 2 historical quarters with both a filed EPS and a matching trading day).

Revenue (June 30, 2026)
₹3 Cr
Net profit (June 30, 2026)
₹-0 Cr
Basic EPS (June 30, 2026)
₹0.2000

Ranks #47 of 62 in Healthcare Services by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter62.66%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 62.66% in Jun 2026 qtr

All shareholding details →

Corporate Actions

Full history (1 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from Shiva Medicare ltd. to BANDARAM PHARMA PACKTECH LIMITED

All corporate actions →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Company Update Bandaram Pharma Packtech Ltd - 524602 - Cancellation Of Board Meeting To Be Held On 30.09.2026

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.66)
  • Strong revenue growth YoY (294.3%)

Weaknesses

  • Low Return on Equity (-3.4%)
  • Thin net profit margin (-12.0%)
  • Declining profit YoY (-32.7%)

Opportunities

Data unavailable.

Threats

  • Down 56.9% over the past year
  • Weak interest coverage (-4159.0x) -- limited cushion against rising rates

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about BANDARAM PHARMA PACKTECH LIMITED

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.